Development of Non-ABO Red Blood Cell Alloantibodies in Patient Undergoing Allogeneic Haematopoietic Stem Cell Transplant-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of Non-ABO Red Blood Cell Alloantibodies in Patient Undergoing Allogeneic Haematopoietic Stem Cell Transplant

Published:2024 Issue:05 Volume:13 Page:162-170
ISSN:2325-7075
Container-title:Case Reports in Clinical Medicine
language:
Short-container-title:CRCM

Author:

Alsuhaibani Ahmed,Batarfi Khalid,Alharbi Ahmed,Alwasel Haya,Alenazi Abdullah,Alotaibi Abdulmohsen,Hassan Jalal,Alotaibi Rayyan,Aziz Hajer,Alharethi Nourah,Alobaidi Sara,Alonayzan Maram,Alharthi Sanad,Alanazi Majd,Alotaibi Sarah,Shareefi Ahmed,Alqahtani Bandar

Publisher

Scientific Research Publishing, Inc.

Reference15 articles.

1. HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA?

2. Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders

3. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant

4. Post-Hematopoietic Stem Cell Transplantation Immune-Mediated Anemia: A Literature Review and Novel Therapeutics

5. Clinical Guide to ABO-Incompatible Allogeneic Stem Cell Transplantation

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP